fbpx
  • Hindi
  • Heritage Edge
  • Sports Edge
  • Wildlife Edge
SHARP. BITTER. NEUTRAL.
No Result
View All Result
  • Login
The Edge Media
Saturday, March 25, 2023
  • Home
  • National Edge
  • State Edge
  • Political Edge
  • World Edge
  • Entertainment Edge
  • Business Edge
  • Sports Edge
  • Home
  • National Edge
  • State Edge
  • Political Edge
  • World Edge
  • Entertainment Edge
  • Business Edge
  • Sports Edge
No Result
View All Result
The Edge Media
No Result
View All Result
Home Health & Medical

Zydus Cadila Launches Remdesivir Under The Brand Name ‘Remdac’

The Edge Media by The Edge Media
3 years ago
in Health & Medical, Main Story, National Edge
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedInShare via TelegramSend To WhatsApp

Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. 


Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing. The company said the drug will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.


Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19, Cadila Healthcare Managing Director Dr. Sharvil Patel said. Through the course of this pandemic, the company’s efforts have been focused on supporting people in this healthcare crisis, whether it is through developing vaccines, ramping up production and distribution of critical drugs and therapies, making diagnostic tests available or exploring new treatment options, Patel added.


In June this year, Zydus had entered into a non-exclusive agreement with Gilead Sciences Inc. to manufacture and sell Remdesivir, the investigational drug, which has been issued an emergency use authorization by the US Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of COVID-19.

– PTI

Tags: RemdacremdesivirUSFDAvaccineZydus Cadila
Previous Post

146 People Arrested for Violence in Bengaluru

Next Post

Congress Spokesperson Rajiv Tyagi Passes Away Due To Cardiac Arrest

Related News

European Medicines Agency lists neurological disorder as a “very rare” side effect of the AstraZeneca Covid-19 vaccine

by The Edge Media
September 9, 2021
0

The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare"...

2 doses of Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech : Study

by The Edge Media
August 31, 2021
0

Two doses of the Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech, a...

Myanmar will vaccinate minority Muslim Rohingya people

by The Edge Media
August 27, 2021
0

Myanmar will vaccinate minority Muslim Rohingya people against the coronavirus, a spokesman for its ruling military said on Friday, adding...

South Africa indicates that it may resume using AstraZeneca vaccine

by The Edge Media
August 6, 2021
0

South Africa has indicated that it may resume inoculations against coronavirus disease (Covid-19) using the AstraZeneca vaccine which the country...

Government may reduce the gap between the two doses of Covishield

by The Edge Media
August 5, 2021
0

The government may again reduce the gap between the two doses of the Covishield vaccine, but this time it will...

Monthly production capacity of vaccines to be increased : Centre

by The Edge Media
August 3, 2021
0

The monthly production capacity of Covishield is projected to be increased to more than 120 million doses and of Covaxin...

Discussion about this post

Recommended

Key takeaway of PM Modi’s meeting regarding J&K

2 years ago
On the Hindutva issue, a BJP leader sneers at Rahul Gandhi: “Pathological Hatred”

On the Hindutva issue, a BJP leader sneers at Rahul Gandhi: “Pathological Hatred”

1 year ago

Popular News

    • Hindi
    • Heritage Edge
    • Sports Edge
    • Wildlife Edge
    SHARP. BITTER. NEUTRAL.

    © 2021 The Edge Media All Rights Reserved.

    No Result
    View All Result
    • Home
    • National Edge
    • State Edge
    • Political Edge
    • World Edge
    • Entertainment Edge
    • Business Edge
    • Sports Edge

    © 2021 The Edge Media All Rights Reserved.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In